Security key
29970R204
Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX)
CUSIP: 29970R204
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
- Total 13F shares
- 453,337
- Total 13F value
- $1,313,498
- Share change
- +72,308
- SEC-reported price per share
- $2.89
- Number of holders
- 6
- Value change
- +$206,104
- Number of buys
- 4
- Number of sells
- 2
- Shares outstanding
- 315,652,014
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
6
Top holders
6
EVAX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Evaxion A/S SEC filings
Evaxion A/S company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29970R204
Recent filing periods:
Ownership snapshot
Top reported holders of EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
6/6
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.12%
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.12%.
6 of 6 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
0.12%
CITADEL ADVISORS LLC
0%
Beacon Capital Management, LLC
0%
JPMORGAN CHASE & CO
0%
RHUMBLINE ADVISERS
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 6 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.12%
|
$1,174,400
367,000 shares
|
— | 31 Mar 2024 |
| CITADEL ADVISORS LLC |
13F
Company
|
0%
|
$26,051
8,141 shares
|
— | 31 Mar 2024 |
| Beacon Capital Management, LLC |
13F
Company
|
0%
|
$15,562
4,863 shares
|
— | 31 Mar 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0%
|
$2,256
705 shares
|
— | 31 Mar 2024 |
| RHUMBLINE ADVISERS |
13F
Company
|
0%
|
$928
290 shares
|
— | 31 Mar 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$96
30 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
6
Shares
453,337
Rows available
6
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q2 2024 holders
6
Holder diff
5
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend